Vericel develops, manufactures, and markets autologous cell-based therapies for patients with serious diseases and conditions. The company markets MACI® (autologous cultured chondrocytes on porcine collagen membrane), a third generation autologous cellularized scaffold product that is indicated for the repair of single or multiple symptomatic, full-thickness cartilage defects of the adult knee, with or without bone involvement.
Victor Zaporojan, MD
From Your Cells to MACI
Add to External Calendar
Select to add the event to your external calendar. Set your calendar to use your time zone and to convert the event properly.
Enter the email address that you signed up with and we will email you a password reset link.
Your session is about to expire.
For your security, this session will expire in due to inactivity. If you want to extend your session, please select the 'Continue' button. If you select the 'Log Out' button or do not respond, your session will automatically close.